Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

FTC challenge to Edwards Lifesciences’ JenaValve acquisition to delay TAVR-AR device approvals, says GlobalData

The US Federal Trade Commission (FTC) recently announced its intention to block Edwards Lifesciences’ acquisition of JenaValve, a medical device company focusing on transcatheter aortic valve replacement for aortic regurgitation (TAVR-AR). The initial complaint brought against Edwards Lifesciences by the FTC includes concerns over competitive dynamics for the TAVR-AR market, as JenaValve and Edwards Lifesciences’ […]
Read more

APAC automotive electric transmission systems market to record 9.5% CAGR over 2025-30, forecasts GlobalData

The automotive landscape in the Asia-Pacific (APAC) region is undergoing a transformative shift, driven by the increasing adoption of electric vehicles (EVs). As countries like China lead the charge in electrification, other nations within APAC are setting ambitious targets to enhance their EV markets, creating a robust environment for innovation and investment in electric transmission […]
Read more

SetPoint Medical’s funding highlights investor confidence in neuromodulation approaches for autoimmune conditions, says GlobalData

SetPoint Medical has recently secured $140 million in private financing to advance the commercial rollout of its SetPoint System, marking a major milestone in neuroimmune therapy for rheumatoid arthritis (RA). This funding underscores strong investor confidence in pioneering neuromodulation approaches to treating chronic autoimmune conditions, says GlobalData, a leading data and analytics company. The SetPoint […]
Read more

APAC automotive camera market to record 0.2% CAGR over 2025-30, forecasts GlobalData

The automotive industry in the Asia-Pacific (APAC) region is experiencing a remarkable transformation, driven by the rapid integration of advanced camera technology. As vehicles become increasingly equipped with sophisticated safety features and autonomous driving capabilities, the demand for automotive cameras is expected to hold the market volume stably. Against this backdrop, the APAC automotive camera […]
Read more

Influencers opine Google Chrome acquisition could potentially be advantageous for Perplexity, reveals GlobalData

Perplexity captured the spotlight among influencers in the mid of August 2025, after making a bold $34.5 billion unsolicited offer to acquire Google Chrome amid the ongoing antitrust scrutiny facing Google. The offer has ignited discussions about the potential ramifications for competition and innovation in the technology industry. Influencers noted that the bid could be […]
Read more

CRISPR-based therapeutics hold potential to combat AMR and cure chronic viral infections, says GlobalData

Clustered regularly interspaced short palindromic repeats (CRISPR)-based therapeutics are rapidly gaining traction for the management of infectious diseases. Programs targeting pathogens such as the human immunodeficiency virus (HIV), herpes simplex virus (HSV), and drug-resistant Escherichia coli (E. coli) are advancing in the clinic, signaling a transformative shift in the infectious disease space. CRISPR-based therapeutics show […]
Read more

Thermo Fisher’s FDA approval for NGS-based companion diagnostic to advance personalization of lung cancer treatment, says GlobalData

The US Food and Drug Administration (FDA) has granted accelerated approval to HERNEXEOS (zongertinib)-a HER2 selective tyrosine kinase inhibitor- for adults with previously treated, unresectable or metastatic non-small cell lung cancer (NSCLC) harboring HER2 tyrosine kinase domain activating mutations. Simultaneously, the FDA approved Thermo Fisher’s Oncomine Dx Target Test as the companion diagnostic (CDx) to […]
Read more

Insmed’s pivotal win in bronchiectasis highlights potential of DPP-1 inhibitor in growing respiratory field, says GlobalData

Following the US FDA approval of Insmed’s Brinsupri for treatment of non-cystic fibrosis bronchiectasis (NCFB): Vinie Varkey, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view: “As the first-to-market therapy, Brinsupri (brensocatib) addresses the top unmet need for NCFB: an approved therapy that can reduce exacerbations and slow down the disease […]
Read more

AI improving idiopathic pulmonary fibrosis care, says GlobalData

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterized by the accumulation of scar tissue in the lungs, leading to respiratory failure and significantly impacting patients’ quality of life. Recent advancements in AI have emerged as a promising tool that can contribute to the management of IPF. AI algorithms that employ machine learning and […]
Read more
1 … 31 32 33 34 35 … 136